164 related articles for article (PubMed ID: 25280574)
1. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.
Abali R; Tasdemir N; Alpsoy S; Tasdemir UG; Guzel S; Yuksel MA; Temel Yuksel I; Yilmaz M
Arch Gynecol Obstet; 2015 May; 291(5):1075-80. PubMed ID: 25280574
[TBL] [Abstract][Full Text] [Related]
2. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
Pepene CE; Ilie IR; Marian I; Duncea I
Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
[TBL] [Abstract][Full Text] [Related]
9. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.
Celik C; Bastu E; Abali R; Alpsoy S; Guzel EC; Aydemir B; Yeh J
Gynecol Endocrinol; 2013 May; 29(5):488-91. PubMed ID: 23480818
[TBL] [Abstract][Full Text] [Related]
10. Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients.
Gunes M; Temizkan S; Apaydin T; Ilgin C; Haklar G; Gogas Yavuz D
J Diabetes Complications; 2021 Dec; 35(12):108073. PubMed ID: 34635402
[TBL] [Abstract][Full Text] [Related]
11. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
13. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P
Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
[TBL] [Abstract][Full Text] [Related]
14. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
[TBL] [Abstract][Full Text] [Related]
16. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
Pepene CE
Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.
Karthik S; Vipin VP; Kapoor A; Tripathi A; Shukla M; Dabadghao P
Hum Reprod; 2019 Aug; 34(8):1559-1566. PubMed ID: 31299073
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
Kahal H; Aburima A; Ungvari T; Rigby AS; Dawson AJ; Coady AM; Vince RV; Ajjan RA; Kilpatrick ES; Naseem KM; Atkin SL
Clin Endocrinol (Oxf); 2013 Aug; 79(2):252-8. PubMed ID: 23278130
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
Tripathy P; Sahu A; Sahu M; Nagy A
Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
